when to increase glp-1 dose THE MICRODOSING PROGRAM Ready to get started on
Description
Adverse drug reaction patterns of GLP-1 receptor agonists approved for obesity treatment
A 32-year-old woman with no prior thyroid history developed painless biphasic thyroiditis (initial hyperthyroidism followed by temporary hypothyroidism) after two months of tirzepatide therapy
Knowing these in advance saves you from learning them the hard way
doi: 10.1093/ejendo/lvac004 28 ChristensenMBLundACalannaSJrgensenNRHolstJJVilsbllTet al
Mounjaro targets both GLP-1 and GIP
